TCR2 Therapeutics Inc. (TCRR) has a market capitalization of $58.11M and trades at $1.48. The 52-week range is 0.821-3.88.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-3.93.
The stock has a beta of 1.93, operates in the Healthcare sector.
